Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by aldo451on Jun 20, 2019 10:22pm

141 Views

Post# 29847582

RE:Selling

Nightblinder wrote: Who is selling this right now? I kind of figured that whoever wanted out would be out by now.. Any ideas? The banks just controlling sp?

	Shares	Price	Cost/Profit
Buy position	100,000	$0.05000	$5,000
Sell after record date	100,000	$0.04000	$4,000
Exercise rights 20/1	2,000,000	$0.01521	$26,420	($30,420 - $4,000)
Sell today	2,000,000	$0.02500	$50,000

		Profit	$23,580	47.16%